← All stocks

Surgery Partners, Inc.

SGRY Net buying
CIK 0001638833 #2115 in the set updated 17 Sep 2026
Bought (1 mo)
$143.50K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$143.50K
+$143.50K against sales at will

By person

17 insiders · 1 transaction
12.5×

J. Eric Evans holds 12.5 times base salary in stock. $13.21M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what J. Eric Evans last reported holding, valued at $14.35, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DeLuca Teresa
Director
$143.50K (1)
+$143.50K
66,843
0.0511%
$959.20K
+14.6%
Evans Jason Eric
Chief Executive Officer
920,386
0.7030%
$13.21M
+100.2%
Baldock Jennifer
Chief Admin & Dev Officer
326,474
0.2494%
$4.68M
+77.8%
Doherty David T
Chief Financial Officer
221,679
0.1693%
$3.18M
+131.6%
Oppenheimer Justin Robert
COO & National Group President
120,259
0.0919%
$1.73M
Bane Harrison R.
National Group President
117,181
0.0895%
$1.68M
+142.9%
DeVeydt Wayne S
Exec Chairman of the Board
105,203
0.0804%
$1.51M
+4.2%
Brittenham Marissa
Chief Strategy Officer
94,196
0.0720%
$1.35M
+136.9%
TURNER BRENT
Director
86,594
0.0661%
$1.24M
+27.2%
Burkhalter Danielle
Chief Human Resources Officer
76,864
0.0587%
$1.10M
+153.2%
Webb William Trenton
American Group President
74,249
0.0567%
$1.07M
+172.2%
ADLERZ CLIFFORD G
Director
69,104
0.0528%
$991.64K
+36.6%
HENDRIX BLAIR E
Director
52,895
0.0404%
$759.04K
Deane John A
Director
45,922
0.0351%
$658.98K
+67.7%
Forese Laura L
Director
18,531
0.0142%
$265.92K
Dean Lloyd H
Director
11,670
0.0089%
$167.46K
Maryland Patricia Anne
Director
4,565
0.0035%
$65.51K
−74.2%
Insider
Date
Role
Action
Shares
Price
Amount
DeLuca Teresa
18 Aug 2026
Director
Buy
10,000
$14.35
$143.50K

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 30 Sep 2016